GGHSX Mutual Fund

NAV$42.90

Fund Essentials - as of Mar 31, 2026

Net Assets
$41,653.64
Expense Ratio
0.72%
Dividend Yield (Current)
5.17%
Holdings
81
Inception Date
Apr 4, 2017
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.70%
1 Year+16.55%
3 Year+9.68%
5 Year+8.62%

Asset Allocation

Stocks: 95.79%
Cash: 4.21%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company9.07%
JNJJOHNSON AND JOHNSON5.81%
AZN:LNAstrazeneca Plc Adr4.34%
GILDGilead Sciences Inc4.10%
ABBVAbbvie Inc Health Care3.67%
Top 10 Concentration: 42.62%Report Date: Mar 31, 2026
Download all 81 holdings for GGHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.17%
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GGHSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GGHSX Mutual Fund Overview

GGHSX Mutual Fund (Invesco Health Care Fund Class R6) is managed by Invesco (US) with $41,653.64 in net assets. GGHSX expense ratio is 0.72%, holding 81 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 2017-04-04.

GGHSX performance shows a YTD return of 3.70%. The 1-year return is 16.55% and the 5-year return is 8.62%. GGHSX dividend yield stands at 5.17%, paid annually.

GGHSX top holdings include Eli Lilly And Company (9.1%), JOHNSON AND JOHNSON (5.8%), Astrazeneca Plc Adr (4.3%), Gilead Sciences Inc (4.1%), Abbvie Inc Health Care (3.7%). View all GGHSX holdings, sector breakdown, or dividend history.

GGHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GGHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.